Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Moodys
McKinsey
Colorcon
McKesson

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR PLECANATIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Plecanatide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01429987 ↗ The Plecanatide Chronic Idiopathic Constipation (CIC) Study Completed Parexel Phase 2/Phase 3 2011-10-01 This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01429987 ↗ The Plecanatide Chronic Idiopathic Constipation (CIC) Study Completed Bausch Health Americas, Inc. Phase 2/Phase 3 2011-10-01 This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01429987 ↗ The Plecanatide Chronic Idiopathic Constipation (CIC) Study Completed Synergy Pharmaceuticals Inc. Phase 2/Phase 3 2011-10-01 This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
NCT01722318 ↗ The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Completed Bausch Health Americas, Inc. Phase 2 2012-11-01 This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
NCT01722318 ↗ The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) Completed Synergy Pharmaceuticals Inc. Phase 2 2012-11-01 This is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Plecanatide

Condition Name

Condition Name for Plecanatide
Intervention Trials
Chronic Idiopathic Constipation 5
Irritable Bowel Syndrome Characterized by Constipation 3
Irritable Bowel Syndrome With Constipation 2
Barrett Esophagus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Plecanatide
Intervention Trials
Constipation 10
Irritable Bowel Syndrome 6
Syndrome 5
Gastroesophageal Reflux 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Plecanatide

Trials by Country

Trials by Country for Plecanatide
Location Trials
United States 301
Canada 8
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Plecanatide
Location Trials
Florida 10
Virginia 10
Texas 10
Louisiana 10
California 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Plecanatide

Clinical Trial Phase

Clinical Trial Phase for Plecanatide
Clinical Trial Phase Trials
Phase 3 7
Phase 2/Phase 3 1
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Plecanatide
Clinical Trial Phase Trials
Completed 9
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Plecanatide

Sponsor Name

Sponsor Name for Plecanatide
Sponsor Trials
Bausch Health Americas, Inc. 10
Synergy Pharmaceuticals Inc. 10
Parexel 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Plecanatide
Sponsor Trials
Industry 22
Other 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Boehringer Ingelheim
Baxter
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.